皮膚科領域における自律神経調節剤トフィソパム(グランダキシン)の使用経験

書誌事項

タイトル別名
  • Clinical Evaluation of Tofisopam (Grandaxin) on Several Dermatological Diseases in Patients with Psychosomatic Symptoms.

説明

The clinical evaluation for tofisopam (GrandaxinR), a known regulator forautonomic nervous system, on severaldermatological diseases in patients withvarious psychosomatic symptoms was performedin open trial (chronic urticaria, 3 cases;pruritus cutaneus, 2 cases; hyperhidrosis, 4cases; alopecia areata, 2 cases, post-herpeticneuralgia, 1 case). The final global improvementwas 100% in urticaria and 50% inpruritus cutaneus, hyperhidrosis and alopecia areata. The effect on postherpetic neuralgiawas slight. Side effect was observed in onlyone case. In conclusion, tofisopam (GrandaxinR) can be regarded to be useful in the field of dermatology.

収録刊行物

  • 皮膚

    皮膚 33 (6), 699-707, 1991

    日本皮膚科学会大阪地方会

詳細情報 詳細情報について

  • CRID
    1390001204799534080
  • NII論文ID
    130003843813
  • DOI
    10.11340/skinresearch1959.33.699
  • ISSN
    1884541X
    00181390
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ